Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.
暂无分享,去创建一个
F. Carrat | A. Rosenberg | O. Lortholary | O. Launay | L. Slama | M. Michel | L. Piroth | D. Rey | N. Colin de Verdière | Karine Martin | D. van der Vliet
[1] Abigail Shefer,et al. Recommended Adult Immunization Schedule: United States, 2011* , 2011, Annals of Internal Medicine.
[2] L. Camacho,et al. High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects. , 2010, Vaccine.
[3] C. Mengoli,et al. Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients. , 2009, Vaccine.
[4] R. Harrington,et al. Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons , 2008, International journal of STD & AIDS.
[5] P. Lambert,et al. Intradermal vaccine delivery: will new delivery systems transform vaccine administration? , 2008, Vaccine.
[6] J. Angel,et al. CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] F. Souto,et al. Effects of vertical HIV infection on the persistence of anti-HBs after a schedule of three doses of recombinant hepatitis B vaccine. , 2008, Vaccine.
[8] R. D. de Man,et al. A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients. , 2008, The Journal of infectious diseases.
[9] G. Siame. Hepatitis B and hepatitis C prevalence in HIV positive pregnant women , 2006, Retrovirology.
[10] A. Duarte,et al. Humoral response to hepatitis B vaccination and its relationship with T CD45RA+ (naïve) and CD45RO+ (memory) subsets in HIV-1-infected subjects. , 2006, Vaccine.
[11] F. Fabrizi,et al. Meta‐analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease , 2006, Alimentary pharmacology & therapeutics.
[12] M. Alter,et al. A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States , 2006, Pediatrics.
[13] G. Ruiz-Palacios,et al. Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses , 2006, AIDS research and therapy.
[14] Y. Chawla,et al. Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine , 2006, BMC infectious diseases.
[15] 横田 俊平,et al. 米国「予防接種の実施に関する諮問委員会」 Advisory Committee on Immunization Practices (ACIP) について : わが国の予防接種プラン策定に新しいシステムの導入を , 2006 .
[16] W. Powderly,et al. Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] Giorgio Palù,et al. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. , 2005, Journal of hepatology.
[18] A. Barone,et al. Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. , 2005, Vaccine.
[19] A. Mocroft,et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort , 2005, AIDS.
[20] A. Moorman,et al. Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] E. Keeffe,et al. Hepatitis B vaccines. , 2004, Clinics in liver disease.
[22] A. McNaghten,et al. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. , 2003, The Journal of infectious diseases.
[23] J. Phair,et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) , 2002, The Lancet.
[24] J. Lang,et al. Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. , 2000, Vaccine.
[25] U. Liebert,et al. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C , 2000, Hepatology.
[26] S. Lemon,et al. Vaccines to prevent viral hepatitis. , 1997, The New England journal of medicine.
[27] M Gesemann,et al. Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence. , 1995, Vaccine.
[28] S. Hadler,et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. , 1986, The New England journal of medicine.